NBIX compared with INCY: revenue, margins and what each company keeps, and the suppliers and customers both name

NBIXNeurocrine Biosciences Inc

Mkt capRevenueRevenue

INCYIncyte Corp

Mkt capRevenueRevenue

Compare

NBIXNeurocrine Biosciences Inc

INCYIncyte Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NBIXNeurocrine Biosciences Inc

145.87▼−0.16%· post 154.00· delayed

Mkt cap$14.9BRevenue$1.1BQ3 FY26Revenue$2.9BFY25

INCYIncyte Corp

120.04▼−0.29%· post 120.07· delayed

After hoursNov 2 '26delayed

Mkt cap$24.5BRevenue$1.6BQ3 FY26Revenue$5.1BFY25

Compare

After hoursNov 2 '26delayed

NBIXNeurocrine Biosciences Inc

INCYIncyte Corp

145.87▼−0.16%post 154.00delayed

Price

120.04▼−0.29%post 120.07delayed

$14.9B

Mkt cap

$24.5B

Q3 FY26$1.1B

Revenue

$1.6BQ3 FY26

FY25$2.9B

Revenue

$5.1BFY25

NBIX145.87▼−0.16%vsINCY120.04▼−0.29%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

INCY: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NBIX 9

ABBVAbbViesupplier

XENEXenon Pharmaceuticalssupplier

KRCKilroy Realtysupplier

MAZEMaze Therapeuticssupplier

5 more · NBIX chain ›

Shared 0

No shared counterparties.

Only INCY 5

MGNXMacrogenicssupplier

PRLDPrelude Therapeuticssupplier

AGENAgenussupplier

—ARIAD/Takedaunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

1 more · INCY chain ›

Price

rebased to 0%

NBIX, solidINCY, dashed